Adenosine Administration in Supraventricular Tachycardia: Single- or Double-Syringe Technique?-Reference-Cited by-同舟云学术

Adenosine Administration in Supraventricular Tachycardia: Single- or Double-Syringe Technique?

Published:2023-05-10 Issue:4 Volume:23 Page:339-340
ISSN:1175-3277
Container-title:American Journal of Cardiovascular Drugs
language:en
Short-container-title:Am J Cardiovasc Drugs

Author:

Zuin Marco^ORCID,Rigatelli Gianluca

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s40256-023-00584-7.pdf

Reference13 articles.

1. Katritsis DG, Boriani G, Cosio FG, et al. European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardiaca y Elect. Eur Heart J. 2018;39:1442–5.

2. Kotadia ID, Williams SE, O’Neill M. Supraventricular tachycardia: an overview of diagnosis and management. Clin Med (Lond). 2020;20:43–7.

3. Wang YS, Scheinman MM, Chien WW, et al. Patients with supraventricular tachycardia presenting with aborted sudden death: incidence, mechanism and long-term follow-up. J Am Coll Cardiol. 1991;18:1711–9.

4. Lerman BB, Markowitz SM, Cheung JW, et al. Supraventricular tachycardia: mechanistic insights deduced from adenosine. Circ Arrhythm Electrophysiol. 2018;11: e006953.

5. Brugada J, Katritsis DG, Arbelo E, et al. ESC guidelines for the management of patients with supraventricular tachycardia. The Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC). Eur Heart J. 2019;2019:ehz467.